ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

NCI High School Summer Program Called Successful

October 19, 1990